Current assets increased 13.3%
Current assets changed +13.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.1B→$1.2B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RGEN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 12.1%
Free-cash-flow proxy changed -12.1% from the comparable as-filed period.
$43.4M→$38.2M2 prior comparisons
Cash / debt moved 835 bp lower
Cash / debt changed -835 basis points from the comparable as-filed period.
139.19%→130.84%0 prior comparisons
Operating cash flow decreased 10.4%
Operating cash flow changed -10.4% from the comparable as-filed period.
$48.1M→$43.1M2 prior comparisons
Operating income changed across a sign change
Operating income changed -275.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$16.8M→-$29.5M2 prior comparisons
Current ratio increased 18.2%
Current ratio changed +18.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
8.36→9.884 prior comparisons
Net income changed across a sign change
Net income changed -357.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$14.9M→-$38.4M2 prior comparisons
Inventory increased 13.7%
Inventory changed +13.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$160.3M→$182.2M4 prior comparisons
Selling, general & administrative increased 13.5%
Selling, general & administrative changed +13.5% from the comparable as-filed period.
$73.7M→$83.6M2 prior comparisons
Net debt increased 18.7%
Net debt changed +18.7% from the comparable as-filed period.
-$210.8M→-$171.4M0 prior comparisons
Research & development increased 1.8%
Research & development changed +1.8% from the comparable as-filed period.
$14.2M→$14.4M2 prior comparisons
Capital expenditure increased 5.2%
Capital expenditure changed +5.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$4.7M→$4.9M2 prior comparisons
Current liabilities decreased 4.2%
Current liabilities changed -4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$131.1M→$125.7M4 prior comparisons
Cost of revenue increased 11.4%
Cost of revenue changed +11.4% from the comparable as-filed period.
$88.3M→$98.3M2 prior comparisons
Cash & equivalents decreased 2.9%
Cash & equivalents changed -2.9% from the comparable as-filed period.
$748.7M→$727.0M3 prior comparisons
Trade receivables increased 1.5%
Trade receivables changed +1.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$149.0M→$151.2M4 prior comparisons
Total assets increased 0.1%
Total assets changed +0.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.9B→$2.9B4 prior comparisons
Debt / assets moved 59 bp higher
Debt / assets changed +59 basis points from the comparable as-filed period.
18.40%→18.99%0 prior comparisons
Stock-based compensation increased 4.3%
Stock-based compensation changed +4.3% from the comparable as-filed period.
$9.0M→$9.4M2 prior comparisons
Reported total debt increased 3.3%
Reported total debt changed +3.3% from the comparable as-filed period.
$537.9M→$555.6M0 prior comparisons
Gross debt increased 3.3%
Gross debt changed +3.3% from the comparable as-filed period.
$537.9M→$555.6M0 prior comparisons
Net income decreased 66.3%
Net income changed -66.3% from the comparable as-filed period.
$14.9M→$5.0M2 prior comparisons
Working capital increased 14.4%
Working capital changed +14.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$933.9M→$1.1B4 prior comparisons
Operating cash flow increased 14.5%
Operating cash flow changed +14.5% from the comparable as-filed period.
$28.6M→$32.8M3 prior comparisons
Operating cash flow / net income increased 240.0%
Operating cash flow / net income changed +240.0% from the comparable as-filed period.
1.92→6.540 prior comparisons
Inventory increased 19.7%
Inventory changed +19.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$155.9M→$186.6M4 prior comparisons
Capital expenditure decreased 24.9%
Capital expenditure changed -24.9% from the comparable as-filed period.
$7.1M→$5.3M3 prior comparisons
Cash & equivalents decreased 14.4%
Cash & equivalents changed -14.4% from the comparable as-filed period.
$708.9M→$606.8M3 prior comparisons
Operating income increased 0.6%
Operating income changed +0.6% from the comparable as-filed period.
$13.9M→$14.0M2 prior comparisons
Shares outstanding increased 0.3%
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes.
56,257,618→56,435,6217 prior comparisons
Research & development increased 3.3%
Research & development changed +3.3% from the comparable as-filed period.
$14.0M→$14.4M2 prior comparisons
Selling, general & administrative increased 7.6%
Selling, general & administrative changed +7.6% from the comparable as-filed period.
$71.2M→$76.6M2 prior comparisons
Total assets increased 1.7%
Total assets changed +1.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.9B→$3.0B4 prior comparisons
Current ratio increased 5.3%
Current ratio changed +5.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
8.59→9.054 prior comparisons
Current liabilities increased 7.8%
Current liabilities changed +7.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$123.0M→$132.7M4 prior comparisons
Stock-based compensation decreased 4.3%
Stock-based compensation changed -4.3% from the comparable as-filed period.
$8.4M→$8.0M2 prior comparisons
Trade receivables increased 0.5%
Trade receivables changed +0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$157.0M→$157.7M4 prior comparisons
Cost of revenue increased 3.1%
Cost of revenue changed +3.1% from the comparable as-filed period.
$91.2M→$94.1M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.